MindMed to Participate in the Jefferies London Healthcare Conference

Rhea-AI Summary

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) announced its participation in the Jefferies London Healthcare Conference from November 15-17, 2022. The company's management team will present on November 16, 2022, at 3:50 p.m. GMT (10:50 a.m. EST). The event will include presentations and one-on-one meetings with investors. A webcast of the presentation will be available for replay for 90 days on MindMed's website. MindMed is focused on developing novel products for brain health disorders, aiming to improve patient outcomes.

NEW YORK, Nov. 11, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that members of the Company's management team will participate in the Jefferies London Healthcare Conference, taking place in London, UK from November 15-17, 2022.

Jefferies London Healthcare Conference
Format: Presentation and one-on-one investor meetings
Presentation Date: Wednesday, November 16, 2022
Presentation Time: 3:50 p.m. GMT/10:50 a.m. EST
Location: London, UK
Webcast Link: https://wsw.com/webcast/jeff255/mnmd/1848852

A replay of the webcast will be available in the "News & Media" section of MindMed's website for 90 days following the presentation.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine, and acetylcholine systems.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

For Media: media@mindmed.co

For Investors: ir@mindmed.co

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/mindmed-to-participate-in-the-jefferies-london-healthcare-conference-301675344.html

SOURCE Mind Medicine (MindMed) Inc.

FAQ

When will MindMed participate in the Jefferies London Healthcare Conference?

MindMed will participate in the Jefferies London Healthcare Conference from November 15-17, 2022, with a presentation on November 16, 2022.

What time is MindMed's presentation at the Jefferies London Healthcare Conference?

MindMed's presentation is scheduled for November 16, 2022, at 3:50 p.m. GMT (10:50 a.m. EST).

Where can I watch the MindMed presentation from the Jefferies London Healthcare Conference?

You can watch the MindMed presentation via webcast, which will be available on their website for 90 days following the event.

What is the focus of MindMed as a biopharmaceutical company?

MindMed focuses on developing novel products aimed at treating brain health disorders and improving patient outcomes.

What stock symbol does MindMed trade under?

MindMed trades under the stock symbol MNMD on NASDAQ.